CA
ABBV icon

Crumly & Associates’s AbbVie ABBV Stock Holding History

Crumly & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$711K Buy
2,825
+163
+6% +$35.1K 0.14% 93
2026
Q1 		$579K Buy
2,662
+405
+18% +$89.8K 0.12% 103
2025
Q4 		$516K Buy
2,257
+1,225
+119% +$279K 0.11% 108
2025
Q3 		$239K Buy
+1,032
New +$210K 0.05% 172
2020
Q3 		– Sell
-2,191
Closed -$215K – 62
2020
Q2 		$215K Buy
+2,191
New +$193K 0.2% 47

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Crumly & Associates's ABBV Position: Q2 2026 in Review

Crumly & Associates increased its AbbVie (ABBV) stake by 6.1% in Q2 2026, buying an estimated $35.1K and bringing the position to 2,825 shares worth $711K. The position accounts for 0.14% of the portfolio, ranked #93.

Crumly & Associates first reported a position in ABBV in Q2 2020 and has held it in 5 quarters since. 2,119 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Crumly & Associates held 2,825 shares of AbbVie worth $711K as of Q2 2026.
  • Crumly & Associates bought 163 AbbVie shares in Q2 2026, an estimated $35.1K.
  • AbbVie made up 0.14% of Crumly & Associates's portfolio in Q2 2026, its #93 holding.
  • Crumly & Associates first reported a position in AbbVie in Q2 2020 and has held it in 5 quarters since.
  • 2,119 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Crumly & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.